Sign Up to Receive Your Personalised Learning Resources
Start Learning
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Increased infliximab clearance in patients hospitalized with severe ulcerative colitis may lead to underexposure
View
Breakthroughs in MASH: Highlights from EASL 2024
View
FDA approves bimekizumab for psoriatic arthritis, ankylosing spondylitis and axSpA
View
Bimekizumab on structural damage in r-axial SpA & remote monitoring vs face-to-face
View
New study reveals elevated cognitive impairment risk in rheumatoid arthritis patients, linked to inflammation and comorbidities
View
Highlights from EULAR 2024: Advancing rheumatology
View
Epinephrine Sublingual Film for Type 1 Allergic Reactions: Key data from #AAAAI2025
View
Study finds comparable cardiovascular risk between JAKi and anti-TNFs in IBD
View
Epinephrine 1mg Nasal Spray Gains Approval for Type I Allergic Reactions in Children Over 4 Years, who Weigh 15 to <30 kg
View
Optimizing Tumour Necrosis Factor Inhibitor Therapy in Rheumatoid Arthritis: Embracing Personalized Medicine
View
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a
.This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.